Renaud Fleurance

Dr. Renaud Fleurance

UCB Biopharma
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
CMCarolina Moraes
Carolina Moraes
CVCamila Valle
Camila Valle
RFRenaud Fleurance
Renaud Fleurance
TSTarek Sharshar
Tarek Sharshar
FBFernando Bozza
Fernando Bozza
Joana D'AvilaJoana D'Avila
Joana D'Avila
Frequently underestimated, encephalopathy or delirium are common neurological manifestations associated with sepsis. Brain dysfunction occurs in up to 80% of cases and is directly associated with increased mortality and long-term neurocognitive consequences. Although the central nervous system (CNS) has been classically viewed as an immune-privileged system, neuroinflammation is emerging as a central mechanism of brain dysfunction in sepsis. Microglial cells are major players in this setting. Here, we aimed to discuss the current knowledge on how the brain is affected by peripheral immune activation in sepsis and the role of microglia in these processes. This review focused on the molecular pathways of microglial activity in sepsis, its regulatory mechanisms, and their interaction with other CNS cells, especially with neuronal cells and circuits.

8 May 2008 in Diseases of Aquatic Organisms
Verified
Journal Article
Closed access
PDF file
RFRenaud Fleurance
Renaud Fleurance
CSC. Sauvegrain
C. Sauvegrain
AMA. Marques
A. Marques
ABA. Le Breton
A. Le Breton
CGC. Guereaud
C. Guereaud
MWM. Wyers
M. Wyers
Histological examinations were carried out on the stomach, pyloric caeca and 4 different parts of the intestine, as well as the rectum, hepatopancreas, gall bladder and spleen of 52 sea bream Sparus aurata spontaneously infected by Enteromyxum leei. Fifteen fish from a non-infected farm were included as a control. Clinical signs appeared only in extensively and severely infected fish. We observed Enteromyxum leei almost exclusively in the intestinal tract, and very rarely in the intrahepatic biliary ducts or gall bladder. We observed heavily infected intestinal villi adjacent to parasite-free villi. Histological changes indicated a parasite infection gradually extending from villus to villus, originating from an initial limited infected area probably located in the rectum. The parasite forms were exclusively pansporoblasts located along the epithelial basement membrane. Periodic acid-Schiff (PAS)-Alcian blue was the most useful histological stain for identifying the parasite and characterising the degree of intestinal infection. We observed severe enteritis in infected fish, with inflammatory cell infiltration and sclerosis of the lamina propria. The number of goblet cells was considerably and significantly decreased in heavily infected fish. The intestines of 4 of the 5 survivor fish were totally free of parasites and showed severe chronic enteritis with a regenerative epithelium, suggesting that an acquired immune process may spontaneously eliminate parasites.

9 August 2018 in Toxicologic Pathology
Verified
Journal Article
Closed access
ARArmando R. Irizarry Rovira
Armando R. Irizarry Rovira
BBBindu M. Bennet
Bindu M. Bennet
BBBrad Bolon
Brad Bolon
ABAnnamaria Braendli-Baiocco
Annamaria Braendli-Baiocco
SCSundeep Chandra
Sundeep Chandra
BZBevin Zimmerman
Bevin Zimmerman
Colorless, intracytoplasmic vacuoles occur in multiple tissues in animals following repeated administration of polyethylene glycol (PEG)-conjugated molecules. The extent of vacuolation depends on physical characteristics and molecular backbone of the PEG and the dose, product, drug target/pharmacology, and duration of exposure. The collective experience gathered from multiple nonclinical toxicology studies of PEGylated biopharmaceuticals indicates that in general, PEG-related vacuolation is not associated with demonstrable cell and tissue damage or dysfunction and is reversible with sufficient duration of drug-free periods. Existing data are insufficient to predict whether nonclinical animal species differ in their sensitivity to develop PEG-associated vacuoles; however, recent data suggest that there may be species differences. Recent comprehensive reviews have addressed the basic challenges in developing PEGylated pharmaceutical products, including general reference to and description of PEG-associated tissue findings. These manuscripts have identified gaps in our current understanding of PEG-associated vacuolation, including the lack of a widely accepted standardized histological terminology and criteria to record and grade the severity of vacuolation as well as insufficient knowledge regarding the nature of the contents of these vacuoles. The goal of this article is to help address some of the gaps identified above by providing points to consider, including a pictorial review of PEG-associated microscopic findings, when evaluating and reporting the extent, severity, and significance (adversity or lack of adversity) of PEG-associated cytoplasmic vacuolation in safety assessment studies. [Box: see text]

1 April 2018 in Toxicology Letters
Verified
Journal Article
Closed access
VGVitalina Gryshkova
Vitalina Gryshkova
AFAlisha Fleming
Alisha Fleming
PMPortia McGhan
Portia McGhan
PRPierrette De Ron
Pierrette De Ron
RFRenaud Fleurance
Renaud Fleurance
ACAndre Nogueira da Costa
Andre Nogueira da Costa

18 January 2021 in Toxicologic Pathology
Verified
Journal Article
Closed access
PDF file
AHA. Peter Hall
A. Peter Hall
JTJeffrey S. Tepper
Jeffrey S. Tepper
MBMolly H. Boyle
Molly H. Boyle
MCMaurice G. Cary
Maurice G. Cary
TFThierry G. Flandre
Thierry G. Flandre
SMSydney Mukaratirwa
Sydney Mukaratirwa
The inhalation route is a relatively novel drug delivery route for biotherapeutics and, as a result, there is a paucity of published data and experience within the toxicology/pathology community. In recent years, findings arising in toxicology studies with inhaled biologics have provoked concern and regulatory challenges due, in part, to the lack of understanding of the expected pathology, mechanisms, and adversity induced by this mode of delivery. In this manuscript, the authors describe 12 case studies, comprising 18 toxicology studies, using a range of inhaled biotherapeutics (monoclonal antibodies, fragment antigen-binding antibodies, domain antibodies, therapeutic proteins/peptides, and an oligonucleotide) in rodents, nonhuman primates (NHPs), and the rabbit in subacute (1 week) to chronic (26 weeks) toxicology studies. Analysis of the data revealed that many of these molecules were associated with a characteristic pattern of toxicity with high levels of immunogenicity. Microscopic changes in the airways consisted of a predominantly lymphoid perivascular/peribronchiolar (PV/PB) mononuclear inflammatory cell (MIC) infiltrate, whereas changes in the terminal airways/alveoli were characterized by simple (“uncomplicated”) increases in macrophages or inflammatory cell infiltrates ranging from mixed inflammatory cell infiltration to inflammation. The PV/PB MIC changes were considered most likely secondary to immunogenicity, whereas simple increases in alveolar macrophages were most likely secondary to clearance mechanisms. Alveolar inflammatory cell infiltrates and inflammation were likely induced by immune modulation or stimulation through pharmacologic effects on target biology or type III hypersensitivity (immune complex disease). Finally, a group of experts provide introductory thoughts regarding the adversity of inhaled biotherapeutics and the basis for reasonable differences of opinion that might arise between toxicologists, pathologists, and regulators.

1 February 2013 in Journal of Comparative Pathology
Verified
Journal Article
Closed access
BWB. Wyrzykowski
B. Wyrzykowski
OAO. Albaric
O. Albaric
SMS. Moreau
S. Moreau
FNF. Nguyen
F. Nguyen
RFRenaud Fleurance
Renaud Fleurance
MCM.-A. Colle
M.-A. Colle